Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Cash Flow: 2018-2025

Historic Net Cash Flow for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to $12.2 million.

  • Neurogene's Net Cash Flow rose 127.46% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 79.63%. This contributed to the annual value of -$11.8 million for FY2024, which is 117.68% down from last year.
  • Per Neurogene's latest filing, its Net Cash Flow stood at $12.2 million for Q3 2025, which was up 202.18% from -$11.9 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Net Cash Flow peaked at $103.2 million during Q4 2023, and registered a low of -$65.8 million during Q1 2025.
  • Moreover, its 3-year median value for Net Cash Flow was -$11.9 million (2025), whereas its average is -$970,636.
  • Data for Neurogene's Net Cash Flow shows a peak YoY increase of 127.46% (in 2025) and a maximum YoY decrease of 3,948.10% (in 2025) over the last 5 years.
  • Over the past 3 years, Neurogene's Net Cash Flow (Quarterly) stood at $103.2 million in 2023, then tumbled by 32.22% to $70.0 million in 2024, then skyrocketed by 127.46% to $12.2 million in 2025.
  • Its last three reported values are $12.2 million in Q3 2025, -$11.9 million for Q2 2025, and -$65.8 million during Q1 2025.